Mark Wildgust: Outstanding Results from the FLAIR Study Presented at EHA25
Mark Wildgust, Vice President, Global Medical Affairs, Oncology at The Janssen Pharmaceutical Companies of Johnson and Johnson, shared a post on X:
“Outstanding results from the FLAIR study presented at EHA25 today and published in the NEJM.”
Title: Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia
Journal: NEJM
Authors: Talha Munir, Sean Girvan, David A. Cairns, Adrian Bloor, David Allsup, Abraham M. Varghese, Satyen Gohil, Shankara Paneesha, Andrew Pettitt, Toby Eyre, Christopher P. Fox, Francesco Forconi, Constantine Balotis, Nicholas Pemberton, Oonagh Sheehy, John Gribben, Nagah Elmusharaf, Simona Gatto, Gavin Preston, Anna Schuh, Renata Walewska, Lelia Duley, Nichola Webster, Surita Dalal, Andrew Rawstron, Dena Howard, Anna Hockaday, Sharon Jackson, Natasha Greatorex, Sue Bell, David Stones, Julia M. Brown, Piers E.M. Patten, Peter Hillmen
Take a moment to look 25 Posts Not to Miss from EHA 2025
-
Oct 3, 2026, 00:25Antiplatelets May Be a Strong Option After Ischemic Stroke in Active Cancer – International Journal of Stroke
-
Oct 3, 2026, 00:24Mavis Agnes Kisakye: Honored to Join UNHLS Leadership in Advancing HIV Diagnostics in Uganda
-
Oct 3, 2026, 00:23Phil Spinella: Blood is for Bleeding, Salt Water is for Cooking pasta, Keeping it simple
-
Oct 3, 2026, 00:21Pablo Corral: The ANGPTL Axis in Dyslipidemia and Cardiovascular Risk
-
Oct 3, 2026, 00:20Raghavendra Rao: The Link Between Chronic Venous Disease and VTE May Be Less Robust Than Previously Thought
-
Oct 3, 2026, 00:19Nicolas Hubacz: Immune Cells in the Embryo
-
Oct 3, 2026, 00:18Kalpana Gupta Shekhawat: Reading Beyond the Numbers – A Deeper Look at Routine Blood Reports
-
Oct 3, 2026, 00:17Paulus Kirchhof: Aortic stiffness – A Consequence of High Blood Pressure, or a Driver, or Both?
-
Oct 3, 2026, 00:17Konstantin Yenkoyan: When Science Steps Outside the Laboratory – ERNA 2026